Terms: = Colorectal cancer AND MAPK1, MAPK2, 5594, ENSG00000100030, P28482, ERK2, p40, PRKM1, p38, p41, ERT1, p41mapk, PRKM2, P42MAPK, ERK AND Treatment
904 results:
1. PTPLAD1 Regulates PHB-Raf Interaction to Orchestrate Epithelial-Mesenchymal and Mitofusion-Fission Transitions in colorectal cancer.
Huang ZJ; Li YJ; Yang J; Huang L; Zhao Q; Lu YF; Hu Y; Zhang WX; Liang JZ; Pan J; Pan YL; He QY; Wang Y
Int J Biol Sci; 2024; 20(6):2202-2218. PubMed ID: 38617530
[TBL] [Abstract] [Full Text] [Related]
2. Structure-Guided Discovery and Preclinical Assessment of Novel (Thiophen-3-yl)aminopyrimidine Derivatives as Potent erk1/2 Inhibitors.
Shuai W; Xiao H; Yang P; Zhang Y; Bu F; Wu Y; Sun Q; Wang G; Ouyang L
J Med Chem; 2024 Apr; 67(8):6425-6455. PubMed ID: 38613499
[TBL] [Abstract] [Full Text] [Related]
3. The Natural Product Secoemestrin C Inhibits colorectal cancer Stem Cells via p38-S100A8 Feed-Forward Regulatory Loop.
Zhou H; Chen M; Zhao C; Shao R; Xu Y; Zhao W
Cells; 2024 Apr; 13(7):. PubMed ID: 38607060
[TBL] [Abstract] [Full Text] [Related]
4. Interleukin-12: Structure, Function, and Its Impact in colorectal cancer.
Zhu Z; Peng Q; Duan X; Li J
J Interferon Cytokine Res; 2024 Apr; 44(4):158-169. PubMed ID: 38498032
[TBL] [Abstract] [Full Text] [Related]
5. Role of deubiquitinase JOSD2 in the pathogenesis of esophageal squamous cell carcinoma.
Wang WP; Shi D; Yun D; Hu J; Wang JF; Liu J; Yang YP; Li MR; Wang JF; Kong DL
World J Gastroenterol; 2024 Feb; 30(6):565-578. PubMed ID: 38463028
[TBL] [Abstract] [Full Text] [Related]
6. Peptide mimetic NC114 induces growth arrest by preventing PKCδ activation and FOXM1 nuclear translocation in colorectal cancer cells.
Taguchi Y; Nakaya T; Aizawa K; Noguchi Y; Maiya N; Iwamoto C; Ohba K; Sugawara M; Murata M; Nagai R; Kano F
FEBS Open Bio; 2024 Apr; 14(4):695-720. PubMed ID: 38425293
[TBL] [Abstract] [Full Text] [Related]
7. Fusobacterium nucleatum promotes tumor progression in KRAS p.G12D-mutant colorectal cancer by binding to DHX15.
Zhu H; Li M; Bi D; Yang H; Gao Y; Song F; Zheng J; Xie R; Zhang Y; Liu H; Yan X; Kong C; Zhu Y; Xu Q; Wei Q; Qin H
Nat Commun; 2024 Feb; 15(1):1688. PubMed ID: 38402201
[TBL] [Abstract] [Full Text] [Related]
8. A growth factor-reduced culture system for colorectal cancer organoids.
Tan R; Zhang Z; Ding P; Liu Y; Liu H; Lu M; Chen YG
Cancer Lett; 2024 Apr; 588():216737. PubMed ID: 38382667
[TBL] [Abstract] [Full Text] [Related]
9. Caffeic acid phenethyl ester mediates apoptosis in serum-starved HT29 colon cancer cells through modulation of heat shock proteins and MAPK pathways.
Yahya S; Sulaiman MK; Sudhandiran G
Cell Biochem Funct; 2024 Mar; 42(2):e3942. PubMed ID: 38379263
[TBL] [Abstract] [Full Text] [Related]
10. Platycodin D induces apoptosis via regulating MAPK pathway and promotes autophagy in colon cancer cell.
Han SH; Lee JH; Woo JS; Jung GH; Jung SH; Han EJ; Park YS; Kim BS; Kim SK; Park BK; Jung JY
Biomed Pharmacother; 2024 Mar; 172():116216. PubMed ID: 38295755
[TBL] [Abstract] [Full Text] [Related]
11. Collagen I-induced VCAN/erk signaling and PARP1/ZEB1-mediated metastasis facilitate OSBPL2 defect to promote colorectal cancer progression.
Lin K; Zhao Y; Tang Y; Chen Y; Lin M; He L
Cell Death Dis; 2024 Jan; 15(1):85. PubMed ID: 38267463
[TBL] [Abstract] [Full Text] [Related]
12. c-Fos regulated by TMPO/erk axis promotes 5-FU resistance via inducing NANOG transcription in colon cancer.
Gui Y; Qian X; Ding Y; Chen Q; Fangyu Ye ; Ye Y; Hou Y; Yu J; Zhao L
Cell Death Dis; 2024 Jan; 15(1):61. PubMed ID: 38233377
[TBL] [Abstract] [Full Text] [Related]
13. KLF7 promotes colon adenocarcinoma progression through the PDGFB signaling pathway.
Zhang Z; Jiang X; Li K; Qiao S; Li M; Mei Y; Ding L; Lv Q; Ding Y; Zhao Y; Lv G; Tan G; Yang H; Li G; Gao X; Liu M
Int J Biol Sci; 2024; 20(1):387-402. PubMed ID: 38164176
[TBL] [Abstract] [Full Text] [Related]
14. Repurposing Metabolic Inhibitors in the treatment of Colon Adenocarcinoma Patient-Derived Models.
Lee B; Lee C; Moon HM; Jo SY; Jang SJ; Suh YA
Cells; 2023 Dec; 12(24):. PubMed ID: 38132178
[TBL] [Abstract] [Full Text] [Related]
15. 1,8-Dihydroxy-3-methoxy-anthraquinone inhibits tumor angiogenesis through HIF-1α downregulation.
Hwang SJ; Cho SH; Bang HJ; Hong JH; Kim KH; Lee HJ
Biochem Pharmacol; 2024 Feb; 220():115972. PubMed ID: 38072164
[TBL] [Abstract] [Full Text] [Related]
16. The mechanism of anticancer effects of some pyrrolopyrimidine derivatives on HT-29 human colon cancer cells.
Ergul M; Kilic-Kurt Z; Aka Y; Kutuk O; Sahin-Inan ZD
Toxicol In Vitro; 2024 Mar; 95():105757. PubMed ID: 38061602
[TBL] [Abstract] [Full Text] [Related]
17. Integrated network pharmacology and metabolomics reveal the action mechanisms of vincristine combined with celastrol against colon cancer.
Ning JY; Ma B; Huang JY; Han L; Shao YH; Wang FY
J Pharm Biomed Anal; 2024 Feb; 239():115883. PubMed ID: 38044218
[TBL] [Abstract] [Full Text] [Related]
18. Elevated expression of CXCL3 in colon cancer promotes malignant behaviors of tumor cells in an erk-dependent manner.
Cheng Y; Yang X; Liang L; Xin H; Dong X; Li W; Li J; Guo X; Li Y; He J; Zhang C; Wang W
BMC Cancer; 2023 Nov; 23(1):1162. PubMed ID: 38031087
[TBL] [Abstract] [Full Text] [Related]
19. Adjuvant Effect of Cinnamon Polyphenolic Components in colorectal cancer Cell Lines.
Palmioli A; Forcella M; Oldani M; Angotti I; Sacco G; Fusi P; Airoldi C
Int J Mol Sci; 2023 Nov; 24(22):. PubMed ID: 38003308
[TBL] [Abstract] [Full Text] [Related]
20. Loss of SETD2 aggravates colorectal cancer progression caused by SMAD4 deletion through the RAS/erk signalling pathway.
Ma C; Liu M; Feng W; Rao H; Zhang W; Liu C; Xu Y; Wang Z; Teng Y; Yang X; Ni L; Xu J; Gao WQ; Lu B; Li L
Clin Transl Med; 2023 Nov; 13(11):e1475. PubMed ID: 37962020
[TBL] [Abstract] [Full Text] [Related]
[Next]
